Navigation Links
PharMEDium Announces National Rollout of Electronic 222 Ordering Initiative
Date:6/9/2008

HUNDREDS OF CUSTOMER HOSPITALS USING ELECTRONIC 222 TO ORDER CLASS II

CONTROLLED SUBSTANCES

SEATTLE, June 9 /PRNewswire/ -- PharMEDium Services, LLC, the leading provider of outsourced hospital pharmacy I.V. compounded solutions, has expanded its first-in-the-industry electronic 222 (e-222) ordering initiative, which enables virtually real-time ordering of Schedule II Controlled Substances versus the more time-consuming traditional process, to all hospitals nationwide.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051202/PHARMEDIUMLOGO)

The company announced the initiative at the American Society of Health-System Pharmacists' Summer Meeting and exhibition here.

Hundreds of customers are now ordering pain management medications through PharMEDium's e-222 system, which applies to the entire line of its pain management services. "Our expansion of e-222 represents an ongoing commitment to patient safety, quality, and superior customer service. The early and fast adoption by our customers represents their partnership with us in helping make e-222 a standard practice across our industry," said David Jonas, PharMEDium's Chairman and Chief Executive Officer.

PharMEDium's new controlled substance ordering system aligns with the efforts of the U.S. Drug Enforcement Administration (DEA) and drug industry leaders to take advantage of e-commerce tools to improve efficiency and effectiveness associated with controlled substances ordering. DEA requires a Form 222 for all orders of Schedule II Controlled Substances, which until recently could only be processed through paper forms. E-222 ordering takes about 20 seconds, versus about 20 minutes for paper orders, according to DEA's Office of Diversion Control (ODC). In addition, the elimination of the paper Form 222 reduces the time it takes to receive an order by one to two days.
'/>"/>

SOURCE PharMEDium Services, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PharMEDium Announces Electronic 222 Ordering Initiative
2. PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs
3. Senetek PLC Announces Key Personnel Appointments
4. QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million
5. Health Robotics Announces IV Station (TM Pending) a Centrally-Controlled,
6. Universal Health Realty Income Trust Announces Dividend Increase
7. Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market
8. American Heartworm Society Announces Heartworm Incidence Survey
9. Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program
10. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
11. DTC Perspectives, Inc. Announces the New DTC Hall of Fame Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Attorney Joseph W. Belluck of Belluck...asbestos have been found in toys in past holiday s...RWEB) December 6, 2009 -- As parents shop for chil... be alert to reports of recalls due to lead paint ...l injury lawyer., , ,“Close to 230,000 child...
(Date:12/5/2009)CAPE TOWN, South Africa, December 5 The first Football,for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors,today (5 December 2009). FIFA President Joseph S. Blatter was join
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
Breaking Medicine News(10 mins):Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3
...ON, May 18 Dr. Andree Bates, President of the Pha...ivering a MasterClass on how to tell if you are ma... Eularis, WHAT: MasterClass on the latest t... WHEN: 12 June 2009, WHERE: 1 Northumberlan...
...ston) - African-American women who were younger at..., were more likely to report a history of childhoo...researcher at Boston University,s Slone Epidemiolo...years). , The study, which appears currently on-l...
...d volume perfusion acquisition, intuitive post-pro...ngine for comprehensive workflow efficiency and pa...d leading cause of death in the United States, str...irst few hours are the defining time when a quick ...
...NING, Germany and FREMONT, Calif., May 18 SCM Mic...SMY), a leading provider of solutions that open th...500 mobile terminal is one of the first upgradeab...d in Germany. , , "With the certification of our...
...RCLIFF MANOR, N.Y., May 18 SETO Holdings, Inc. (P...itive agreement to acquire from Sanjay Srivastava ...ers, Inc. ("AHC"), a Maryland corporation formed i...f the AHC acquisition that the public company shal...
...al trials using new strategies show promise for be...y 18 (HealthDay News) -- Vaccines made up of virus...longer-lasting protection against flu viruses than...ce as quickly as conventional vaccines, according ...
Other Medicine News:Health News:MEDIA ALERT - Eularis to Hold Pharmaceutical Marketing ROI MasterClass in London 2Health News:Study finds higher prevalence of early menarche among survivors of childhood sexual abuse 2Health News:Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009 2Health News:Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009 3Health News:Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009 4Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 2Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 3Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 4Health News:SETO Holdings, Inc. Signs Agreement to Acquire Advanced Hearing Centers, Inc. and Will Dispose of All Existing Business; New Management to be Installed 2Health News:New Methods Could Speed Production of Flu Vaccines 2
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 49063 1AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 49063 2AMP urges inclusion of molecular diagnostic tests in comparative effectiveness research 49063 3Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy 8857 1Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy 8857 2Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 1Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 2
... Animal Use in Cosmetics and Chemicals Testing, A...d,that results of a recently completed US and Euro...on MatTek,s EpiDerm in vitro human skin tissue,equ...d sensitivity and,specificity for EpiDerm to be ac...g for determining human skin irritation by the Eur...
...am to evaluate TAXUS(R) Element(TM) Platinum Chrom..., Mass., Oct. 8 Boston Scientific,Corporation (NY...nrollment in,the PERSEUS trial, designed to evalua...(TM) paclitaxel-eluting coronary stent. The PERSEU...nts at 100 U.S. and,international centers since Ju...
Other Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4
Impulse II
Slimtine S
Fineline II Sterox Atrial J
VascoTip P 9/60 PU M
Medicine Products: